Vitalis Therapeutics
New York, US · Delaware corporation
Founders & leadership
JH
Joseph HabbousheNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2022
▶$2MraisedFeb 2025 · 14 investors · PharmaceuticalsRule 506(b)
▶$2MraisedFeb 2025 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph HabbousheDirector, Executive Officer
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Vitalis Therapeutics raised?
- Vitalis Therapeutics has disclosed $2M raised across 1 round.
- Where is Vitalis Therapeutics headquartered?
- Vitalis Therapeutics is headquartered in New York, US.